SocraTec R&D offers a broad range of support for your clinical development programm. With our own Clinical Pharmacology Unit with a capacity of up to 58 beds including 6 intense monitoring units, we can realise most of the phase-I trials of a classical clinical programme. Our excellent access to patient populations of different types opens the door to highly sophisticated phase-II trials.
In the OTC field we have developed excellent structures to realise phase-III trials in a monocentric setting. Patients suffering from diseases which do not necessarily require a physician’s visit are recruited in the surrounding areas of Erfurt. Our good reputation in the local population makes recruitment easy and fast.
Of course as a mid-size CRO we cannot realise everything – however, over more than a decade of clinical activities we have specialised in several indications for phase-III trials in Germany and together with our partners also Europe-wide.
In the meantime we have intensified our non-interventional study activities, from sponsor-initiated non-interventional studies up to PASS, PAES and DUS – our team at SocraTec C&S offers high-standard support.